Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128627) titled 'Effect and Mechanism of Adalimumab-Loaded CeO2@mCS Nano Core-Shell Microspheres on hDPSCs-Mediated Dentin Regeneration under Inflammatory Conditions' on July 23.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Beijing Stomatological Hospital , Capital Medical University
Condition:
Pulpitis
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-08-01
Target Sample Size: One group:20;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=331881
Disclaimer: Curated by HT Syndication....